A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Apr 2018
At a glance
- Drugs Umirolimus (Primary) ; Aspirin
- Indications Acute coronary syndromes; Angina pectoris; Ischaemia
- Focus Therapeutic Use
- Acronyms LEADERS FREE II
- 03 Apr 2018 Planned End Date changed from 1 Sep 2021 to 1 Sep 2020.
- 03 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Sep 2018.
- 19 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Mar 2018.